Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2014-03-30
Product name
CHEMFOS 158
supplier name
Pretreatment and Specialty Products
Icons in SDS
Company Information
company name
Pretreatment and Specialty Products
GHS Information
Signal word
DANGER!
Section 2
SECTION 2: Hazards identification
Emergency overview DANGER! OXIDIZER. CONTACT WITH OTHER MATERIAL MAY CAUSE FIRE. CAUSES EYE AND SKIN BURNS. CAUSES RESPIRATORY TRACT IRRITATION. MAY BE HARMFUL IF INHALED OR SWALLOWED. CONTAINS MATERIAL THAT MAY CAUSE TARGET ORGAN DAMAGE, BASED ON ANIMAL DATA. Add this product only to water. Never add water to this product. Keep away from combustible material. Do not swallow. Do not get in eyes or on skin or clothing. Avoid breathing vapor or mist. Use only with adequate ventilation. Keep container tightly closed and sealed until ready for use. Wash thoroughly after handling.
Potential Acute Health Effects
Inhalation : May be harmful if inhaled. Irritating to respiratory system. Can irritate eyes, nose, mouth and throat. Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure. Ingestion May be harmful if swallowed. May cause burns to mouth, throat and stomach. Skin : Corrosive to the skin. Causes burns. Eyes : Corrosive to eyes. Causes burns. Over-exposure signs/symptoms Inhalation : Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion : Adverse symptoms may include the following: stomach pains Skin : Adverse symptoms may include the following: pain or irritation redness blistering may occur Eyes : Adverse symptoms may include the following: pain watering redness Medical conditions Pre-existing disorders involving any target organs mentioned in this MSDS as being at aggravated by over- risk may be aggravated by over-exposure to this product. exposure This Material Safety Data Sheet has been prepared in accordance with Canada's Workplace Hazardous Materials Information System (WHMIS). See toxicological information (Section 11)